Skip to main content
logo
Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
7.60
+0.20 (2.70%)
Oct 15, 2026, 2:13 PM EDT - Market open

Phathom Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
6041,180555523462596
Market Cap Growth
-32.09%112.56%6.22%13.23%-22.48%-36.35%
Enterprise Value
9731,628740535464461
Last Close Price
7.4016.598.129.1311.2219.67

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2.536.7410.05766.45--
PB Ratio
--2.69-2.19-7.18-6.178.25
P/TBV Ratio
-----8.25

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
4.079.3013.39785.10--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.60-1.34-2.19-6.13-2.761.27
Net Debt / Equity Ratio
-1.07-1.05-1.02-0.89-0.68-1.27
Net Debt / EBITDA Ratio
-9.21-2.88-0.93-0.39-0.300.68
Net Debt / FCF Ratio
-10.01-2.75-0.96-0.46-0.350.62
Asset Turnover
0.830.550.140.00--
Inventory Turnover
7.355.183.61---
Quick Ratio
1.821.583.929.885.929.69
Current Ratio
1.921.734.2010.256.129.86
Return on Equity (ROE)
------108.01%
Return on Assets (ROA)
-8.80%-31.37%-43.78%-36.14%-60.85%-34.85%
Return on Capital Employed (ROCE)
-23.50%-125.90%-94.80%-44.60%-124.40%-79.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-16.33%-18.75%-60.21%-38.57%-42.83%-24.16%
FCF Yield
-6.08%-14.15%-48.07%-26.63%-31.97%-24.98%
Buyback Yield / Dilution
-11.72%-15.42%-23.18%-31.11%-5.72%-11.36%
SEC Filings: 10-K · 10-Q